Michael Taylor

44PUBLICATIONS
431CO-AUTHORS
Infant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMolecular targetsReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Mar 26, 2026
Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma.

Jiao Zhang, Winnie Ong, Alexandra Rasnitsyn

|Mar 11, 2026
Immunotherapy approaches for the treatment of relapsed or progressive medulloblastoma.

Mohammad H Abu-Arja, Austin Stuckert, Rahawa T Ghebrelul

|Mar 11, 2026
An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features.

Yu Su, Kaiwen Deng, Xuan Chen

|Mar 02, 2026
Publisher Correction: An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.

Jamie Zagozewski, Ghazaleh M Shahriary, Ludivine Coudière Morrison

|Feb 04, 2026
ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression.

Siva Kumar Natarajan, Joanna Lum, James Haggerty Skeans

|Jul 25, 2025
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy.

Cory M Richman, Alexandra Rasnitsyn, Borja L Holgado

Pageof 8

Frequent Collaborators

14 joint publications

Vijay Ramaswamy

9 joint publications

Olivier Saulnier

9 joint publications

Hiromishi Suzuki

7 joint publications

Jeremy N Rich